Clinical utility of a small dense LDL cholesterol measurement reagent in coronary artery disease (CAD)
Not Applicable
Completed
- Conditions
- coronary artery disease (CAD)
- Registration Number
- JPRN-UMIN000027504
- Lead Sponsor
- Showa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 3625
Inclusion Criteria
Not provided
Exclusion Criteria
none
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Association between clinical information and clinical course 10 years after blood collection.
- Secondary Outcome Measures
Name Time Method We will group sdLDL-C values by sex and concentration to examine their associations with coronary lesion severity and cardiovascular events over 10 years in order to determine the blood concentrations of sdLDL-C associated with varying degrees of coronary artery disease severity. We will also compare values of LDL-C and non-HDL cholesterol.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link small dense LDL cholesterol to coronary artery disease progression in JPRN-UMIN000027504?
How does sdLDL measurement compare to LDL-C and apoB in predicting CAD outcomes in observational studies?
What biomarkers correlate with sdLDL cholesterol levels for CAD risk stratification in the JPRN-UMIN000027504 trial?
Are there adverse effects associated with sdLDL cholesterol measurement reagents in CAD patient monitoring?
What drug classes synergize with sdLDL cholesterol monitoring to improve CAD management in high-risk patients?